Actinium-225 Decay Chain Delivers Tumor Dose More Efficiently Than Thorium-227 in Simulations
Monte Carlo simulations show that alpha particles from the actinium-225 decay chain dominate tumor dose delivery and that retaining bismuth-213 ...
Tag: bismuth-213
Alpha-particle therapy shows preclinical promise against bladder cancer cells
A preclinical study reports that 213Bi-labeled trastuzumab plus cetuximab killed human bladder cancer cells in vitro through irreparable DNA damage.
POPULAR NEWS
-
Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant
-
Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast
-
ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth
-
Systematic review maps sustainability tensions in offshore wind development